Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Basal Health vs Invyncible

Basal Health
Graded #494

Lower grade

vs+13.299999999999997
Invyncible
Graded #303

Higher grade

The verdict

Invyncible takes it — 61/100 to 47.7/100.

Invyncible grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +10
45
55
Dose & formulationInvyncible +24
40
64
Clinical oversightInvyncible +22
48
70
Labs & monitoringInvyncible +2
50
52
FulfillmentInvyncible +7
58
65
Contract termsInvyncible +6
55
61
Basal Health · left barInvyncible · right bar

The numbers

MetricBasal HealthInvyncible
WeighScore47.7/10061/100
GradeCC
Scorecard rank#494#303
SemaglutideNot disclosed$192/mo (0.5 mg dose, compounded)
TirzepatideNot disclosed$210/mo (compounded)
CoverageAll 50 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Basal Health

Graded #494 · C

Strengths

  • Stated nationwide coverage (50 states + DC)
  • Metabolic-framework positioning rather than single-product
  • Clinician-supervised dosing rather than a fixed protocol
  • Adaptive monitoring approach

Where it loses points

  • No pricing shown publicly — you must complete intake to see cost
  • Compounding pharmacy partner not named
  • GLP-1 molecules not specified (semaglutide vs tirzepatide vs oral)
  • No LegitScript badge visible on the homepage
  • No FDA compounded-medication disclaimer on the pages reviewed
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard